[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100632189":3},{"organization":4,"outcomesModule":7,"designInfo":25,"detailedDescription":24,"studyPopulation":24,"armGroups":33,"interventions":45,"overallOfficials":55,"centralContacts":60,"locations":70,"responsibleParty":88,"collaborators":24,"id":92,"slug":24,"hasResults":93,"nctId":94,"briefTitle":95,"officialTitle":96,"acronym":97,"eligibilityCriteria":98,"healthyVolunteers":93,"sex":99,"minAge":100,"maxAge":24,"enrollmentInfo":101,"targetDuration":24,"studyType":104,"phases":105,"briefSummary":107,"conditions":108,"keywords":111,"overallStatus":73,"whyStopped":24,"lastUpdateSubmitDate":119,"lastUpdatePostDateStruct":120,"startDateStruct":123,"completionDateStruct":125,"leadSponsor":127,"locationsCount":128},{"fullName":5,"class":6},"Poznan University of Medical Sciences","OTHER",{"primaryOutcomes":8,"secondaryOutcomes":13,"otherOutcomes":24},[9],{"measure":10,"description":11,"timeFrame":12},"time-weighted average of mean arterial pressure below 65 mmHg (TWA-MAP \u003C 65 mmHg)","The primary outcome is the time-weighted average of mean arterial pressure below 65 mmHg (TWA-MAP \\\u003C 65 mmHg) during the period from induction of anaesthesia to departure from the operating theatre.","From the beginning of the anesthesia to the end of anesthesia (from induction - start of anesthesia to end of anesthesia - discharge from the post anesthesia department), assessed up to 30 days",[14,18,21],{"measure":15,"description":16,"timeFrame":17},"Composite postoperative organ complications within 7 days","At least one of the following:\n\n* Acute kidney injury (AKI) according to KDIGO criteria\n* Myocardial injury after non-cardiac surgery (MINS), defined as troponin elevation ≥ assay-specific 99th percentile upper reference limit\n* Stroke (new focal neurological deficit confirmed by neuroimaging)\n* Postoperative respiratory failure will be defined as a composite endpoint reflecting clinically relevant impairment of gas exchange or ventilation in the early postoperative period. It will be considered present if at least one of the following criteria is met within 7 days after surgery or before ICU discharge:\n\n  1. Prolonged invasive mechanical ventilation, defined as failure to extubate within 48 hours after the end of surgery;\n  2. Unplanned reintubation with initiation of invasive mechanical ventilation due to respiratory failure (hypoxaemia, hypercapnia, or inability to maintain adequate ventilation) after initial extubation; or\n  3. Unplanned initiation of non-invasive ventilation or high-flo","7 postoperative days",{"measure":19,"description":20,"timeFrame":12},"Intraoperative hypertension","* Total time with MAP \\> 90 mmHg (minutes and % of monitoring time)\n* Total time with MAP \\> 100 mmHg (minutes and % of monitoring time)\n* TWA-MAP \\> 90 mmHg and TWA-MAP \\> 100 mmHg",{"measure":22,"description":22,"timeFrame":23},"All-cause mortality at 90 days","postoperative 90 days",null,{"allocation":26,"interventionModel":27,"interventionModelDescription":24,"primaryPurpose":28,"observationalModel":24,"timePerspective":24,"maskingInfo":29},"RANDOMIZED","PARALLEL","PREVENTION",{"masking":30,"maskingDescription":24,"whoMasked":31},"SINGLE",[32],"OUTCOMES_ASSESSOR",[34,40],{"label":35,"type":36,"description":37,"interventionNames":38},"HPI-guided haemodynamic management (HPI group)","ACTIVE_COMPARATOR","Patients allocated to the HPI group will receive haemodynamic monitoring using the Acumen IQ sensor (Edwards Lifesciences, Irvine, CA, USA) connected to the radial arterial line. The Acumen IQ system provides all parameters available with the FloTrac sensor, plus additional advanced metrics including dynamic arterial elastance (Ea\\_dyn), the rate of ventricular pressure change (dP\u002Fdt), and the Hypotension Prediction Index (HPI).\n\nThe HPI is a machine learning-derived value ranging from 0 to 100 that represents the probability of MAP falling below 65 mmHg within the next 15 minutes. When HPI exceeds 85, the system generates an alert and displays a secondary screen presenting real-time haemodynamic parameters and suggested interventions. Haemodynamic management in the HPI group will follow a structured protocol incorporating both predictive (HPI-triggered) and reactive (MAP-based) components.",[39],"Device: HPI guided heamodynamic monitoring",{"label":41,"type":36,"description":42,"interventionNames":43},"standard arterial pressure-derived cardiac output monitoring (FloTrac group)","Patients allocated to the FloTrac group will receive haemodynamic monitoring using the FloTrac sensor (Edwards Lifesciences, Irvine, CA, USA) connected to the radial arterial line. The FloTrac system provides continuous measurements of cardiac output (CO), cardiac index (CI), stroke volume (SV), stroke volume index (SVI), stroke volume variation (SVV), systemic vascular resistance (SVR), and systemic vascular resistance index (SVRI) based on arterial pressure waveform analysis.\n\nHaemodynamic management in the FloTrac group will follow a structured protocol designed to maintain MAP ≥ 75 mmHg while avoiding excessive hypertension (target MAP ≤ 100 mmHg).",[44],"Device: Standard Heamodynamic Managament according to APCO Monitoring",[46,51],{"type":47,"name":48,"description":49,"armGroupLabels":50,"otherNames":24},"DEVICE","HPI guided heamodynamic monitoring","The investigators hypothesise that HPI-guided haemodynamic management, when implemented with protocol refinements to mitigate hypertensive overcorrection, will reduce the burden of intraoperative hypotension compared with standard APCO monitoring in patients undergoing major abdominal aortic surgery. Secondary objectives include evaluation of postoperative organ injury, assessment of intraoperative hypertension as a safety outcome, and characterisation of fluid and vasopressor requirements. By testing this hypothesis in a rigorously designed, adequately powered trial, the investigators aim to clarify whether predictive haemodynamic monitoring offers clinically meaningful advantages over current reactive approaches in this high-risk population.",[35],{"type":47,"name":52,"description":53,"armGroupLabels":54,"otherNames":24},"Standard Heamodynamic Managament according to APCO Monitoring","Standard Heamodynamic Managament according to APCO Monitoring with MAP target of 75 mmHg",[41],[56],{"name":57,"affiliation":58,"role":59},"Paweł Sobczyński, Professor","Department of Anesthesiology and Intensive Therapy, Poznan University of Medical Sciences","STUDY_CHAIR",[61,66],{"name":62,"role":63,"phone":64,"phoneExt":24,"email":65},"Jakub Szrama, PhD","CONTACT","+48611613280","jakub.szrama@usk.poznan.pl",{"name":67,"role":63,"phone":68,"phoneExt":24,"email":69},"Mariusz Gezela","+48611613250","mariusz.gezela@usk.poznan.pl",[71],{"facility":72,"status":73,"city":74,"state":75,"zip":76,"country":77,"countryCode":78,"cosmosGeoPoint":79,"geoPoint":84,"contacts":85},"Department of Anesthesiology and Intensive Therapy","RECRUITING","Poznan","Poznań","61-355","Poland","PL",{"type":80,"coordinates":81},"Point",[82,83],16.92993,52.40692,{"lat":83,"lon":82},[86,87],{"name":62,"role":63,"phone":64,"phoneExt":24,"email":65},{"name":67,"role":63,"phone":68,"phoneExt":24,"email":69},{"type":89,"investigatorFullName":90,"investigatorTitle":91,"investigatorAffiliation":5,"oldNameTitle":24,"oldOrganization":24},"PRINCIPAL_INVESTIGATOR","Jakub Szrama","PhD","100632189",false,"NCT07510451","The Hypotension Prediction Index Versus Standard Advanced Haemodynamic Monitoring in Patients Undergoing Major Aortic Surgery","The Hypotension Prediction Index Software Compared With Standard Advanced Haemodynamic Monitoring in Patients Undergoing Major Aortic Surgery: A Prospective Randomized Controlled Trial","HYPE-AORTA","Inclusion Criteria:\n\n1. Age ≥ 18 years\n2. American Society of Anesthesiologists (ASA) physical status classification III or IV\n3. Scheduled for elective major abdominal aortic surgery (open or endovascular repair) with an expected surgical duration exceeding 2 hours\n4. Able to provide written informed consent\n\nExclusion Criteria:\n\n1. Emergency or urgent surgery\n2. Pregnancy or breastfeeding or positive\u002Funcertain pregnancy test\n3. Haemodynamically significant valvular heart disease:\n\n   * Severe aortic stenosis (aortic valve area \\\u003C 1.5 cm\\^2)\n   * Moderate to severe aortic regurgitation\n   * Moderate to severe mitral regurgitation\n   * Moderate to severe mitral stenosis\n4. Severe heart failure with left ventricular ejection fraction \\\u003C 35%\n5. Permanent atrial fibrillation (reduces accuracy of pulse contour analysis)\n6. Inability to provide informed consent\n7. Participation in another interventional trial that may influence haemodynamic management or study outcomes","ALL","18 Years",{"count":102,"type":103},200,"ESTIMATED","INTERVENTIONAL",[106],"NA","The standard procedure during general anesthesia is to monitor vital functions, including cardiovascular functions such as cardiac electrical activity, using continuous ECG recording, blood pressure measurement with a sphygmomanometer, heart rate measurement, and tissue oxygenation measurement with a pulse oximeter. These are non-invasive methods, which are often insufficient in the case of extensive procedures within the abdominal aorta. In such cases, the anesthesiologist additionally use direct blood pressure measurements and central venous pressure measurements. To perform these measurements, it is necessary to insert a cannula into an artery (usually the radial artery) and a catheter into the central veins (through the internal jugular or subclavian vein). Vascular cannulation is an invasive method and may be associated with complications such as vascular thrombosis, infection at the puncture site or catheter-related infections, pneumothorax, air embolism, cardiac arrhythmias, neuropathies, hematomas, and bleeding. At the same time, they allow for a more accurate assessment of cardiovascular function and the implementation of appropriate treatment, including the administration of large amounts of infusion fluids, vasoconstrictors, and cardiac support drugs.\n\nIn the current study, the investigators will additionally use a special sensor and monitor to assess the heart's performance (cardiac output) and its response to the treatment used, optimizing and supporting the circulatory system. This monitoring requires the insertion of a catheter into a central vein and artery, which is necessary during vascular surgery procedures and does not involve any additional invasive procedures. In the postoperative period, the investigators will analyze the frequency of abnormalities in laboratory tests routinely collected after surgery and the function of the central nervous system by performing simple non-invasive cognitive function tests.\n\nThe benefits of using the method of assessing the patient's response to surgery and anesthesia in presented study are related to increased safety for each patient and improved perioperative treatment for all patients undergoing surgery.",[109,110],"Elective Endovascular Abdominal Aortic Surgery With an Expected Surgical Duration Exceeding 2 Hours","Elective Open Abdominal Aortic Surgery With an Expected Surgical Duration Exceeding 2 Hours",[112,113,114,115,116,117,118],"hypotension","Hypotension Prediction Index","Acumen IQ","FloTrac","haemodynamic monitoring,","aortic abdominal surgery","major vascular surgery","2026-04-23",{"date":121,"type":122},"2026-04-28","ACTUAL",{"date":124,"type":122},"2026-04-12",{"date":126,"type":103},"2028-06",{"name":5,"class":6},1]